Trial Profile
A Phase II Study to Evaluate the Efficacy of Anti-Fibrin Humanized Monoclonal Antibody(DI-DD3B6/22-80B3) Fab' Fragment (ThromboView®) Conjugated With Technetium-99m in the Detection of Pulmonary Emboli
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Anti-fibrin monoclonal antibody 3B6-22 Tc 99m (Primary)
- Indications Pulmonary embolism
- Focus Diagnostic use
- Sponsors AGEN Biomedical
- 04 Jun 2014 New trial record